...
首页> 外文期刊>International journal of molecular medicine >Rho-kinase regulates thrombin-stimulated interleukin-6 synthesis via p38 mitogen-activated protein kinase in osteoblasts
【24h】

Rho-kinase regulates thrombin-stimulated interleukin-6 synthesis via p38 mitogen-activated protein kinase in osteoblasts

机译:Rho激酶通过p38丝裂原活化蛋白激酶在成骨细胞中调节凝血酶刺激的白介素6合成

获取原文

摘要

We have previously reported that thrombin stimulates synthesis of interleukin-6 (IL-6), a potent bone resorptive agent, in osteoblast-like MC3T3-E1 cells. In the present study, we investigated the mechanism of thrombin in the thrombin-stimulated IL-6 synthesis and the involvement of Rho-kinase in MC3T3-E1 cells. Thrombin time-dependently induced the phosphorylation of p44/p42 mitogen-activated protein (MAP) kinase, p38 MAP kinase, stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) and myosin phosphatase targeting subunit-1 (MYPT-1), a Rho-kinase substrate. While SP600125, an inhibitor of SAPK/JNK, failed to reduce IL-6 synthesis, PD98059, a specific inhibitor of MEK, and SB203580 and BIRB0796, potent inhibitors of p38 MAP kinase, suppressed the IL-6 synthesis induced by thrombin. Y27632, a specific Rho-kinase inhibitor, significantly reduced thrombin-stimulated IL-6 synthesis as well as the MYPT-1 phosphorylation. Fasudil, another inhibitor of Rho-kinase, suppressed thrombin-stimulated IL-6 synthesis. Y27632 and fasudil failed to affect thrombin-induced phosphorylation of p44/p42 MAP kinase. Y27632 as well as fasudil attenuated thrombin-induced phosphorylation of p38 MAP kinase. These results strongly suggest that Rho-kinase regulates thrombin-stimulated IL-6 synthesis via p38 MAP kinase activation in osteoblasts.
机译:我们以前曾报道过,凝血酶可在成骨细胞样MC3T3-E1细胞中刺激白细胞介素6(IL-6)(一种有效的骨吸收剂)的合成。在本研究中,我们研究了凝血酶在凝血酶刺激的IL-6合成中的机制以及Rho激酶在MC3T3-E1细胞中的参与。凝血酶时间依赖性地诱导p44 / p42丝裂原激活蛋白(MAP)激酶,p38 MAP激酶,应激激活蛋白激酶/ c-Jun N末端激酶(SAPK / JNK)和肌球蛋白磷酸酶靶向亚基1( MYPT-1),Rho激酶底物。 S600 / JNK抑制剂SP600125未能降低IL-6的合成,MEK的特异性抑制剂PD98059以及p38 MAP激酶的有效抑制剂SB203580和BIRB0796却抑制了凝血酶诱导的IL-6合成。特定的Rho激酶抑制剂Y27632显着减少了凝血酶刺激的IL-6合成以及MYPT-1磷酸化。 Fasudil,Rho激酶的另一种抑制剂,抑制凝血酶刺激的IL-6合成。 Y27632和法舒地尔未能影响凝血酶诱导的p44 / p42 MAP激酶的磷酸化。 Y27632以及法舒地尔减弱了凝血酶诱导的p38 MAP激酶的磷酸化。这些结果强烈表明,Rho激酶通过成骨细胞中的p38 MAP激酶激活来调节凝血酶刺激的IL-6合成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号